Personalis Sees Q4 Revenue $19M-$20M Vs $18.12M Est.; FY23 Revenue $73M-$74M Vs $70.6M Est.
Portfolio Pulse from Benzinga Newsdesk
Personalis has updated its Q4 2023 revenue forecast to $19M-$20M, higher than the estimated $18.12M. The company also expects FY23 revenue to be between $73M-$74M, surpassing the $70.6M estimate. The increase in revenue is attributed to pharma tests, enterprise sales, and other customers. The company also expects a net loss of approximately $103M, a reduction from $113M in 2022, due to headcount reduction savings and other factors.
November 08, 2023 | 1:44 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Personalis has raised its revenue forecasts for Q4 2023 and FY23, which could positively impact its stock. The company also expects a reduced net loss in 2023, which could further boost investor confidence.
Personalis has raised its revenue forecasts for both Q4 2023 and FY23, which indicates a positive outlook for the company's financial performance. This could lead to increased investor confidence and a potential rise in the company's stock price. Additionally, the company's expectation of a reduced net loss in 2023 could further boost investor sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100